Trials / Completed
CompletedNCT05068193
A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers
A Randomized, Open-label, Single Dose, Two-way Crossover Study to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to compare the pharmacokinetics and bioequivalence of BR2008 with BR2008-1 in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BR2008-1 (R) | After fasting at least 10 hours, two tablets of BR2008-1 will be administered orally with 150mL of water around 8 a.m. |
| DRUG | BR2008 (T) | After fasting at least 10 hours, one tablet of BR2008 will be administered orally with 150mL of water around 8 a.m. |
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2021-11-28
- Completion
- 2022-01-06
- First posted
- 2021-10-05
- Last updated
- 2022-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05068193. Inclusion in this directory is not an endorsement.